The New Era of Tinnitus Treatment

Quick Answer

For millions of people living with tinnitus, one sentence has caused an extraordinary amount of frustration: “You just have to learn to live with it.”

For decades, patients experiencing ringing, buzzing, hissing, humming, or other phantom sounds have often encountered some version of that message. But tinnitus science is changing. Researchers are investigating what happens to auditory nerve fibers after hearing damage. Neuroscientists are studying abnormal patterns of neural activity and plasticity. Scientists are exploring how the auditory and somatosensory systems interact. Audiologists are developing more comprehensive clinical protocols. And patient advocates are demanding that researchers focus on the outcomes that matter most to people actually living with tinnitus.

Increasingly, these conversations are intersecting. That convergence will be on display October 23–24, 2026, when scientists, audiologists, clinicians, and patient advocates gather at Suffolk University in Boston for a two-day professional tinnitus summit. Among those participating are Stéphane Maison, Ph.D., CCC-A, of Massachusetts Eye and Ear and Harvard Medical School; Susan Shore, Ph.D., Professor Emerita at the University of Michigan; neuroscientist and audiologist Keith Darrow, Ph.D.; audiologist and tinnitus specialist Layne Garrett, Au.D.; and Hazel Goedhart, founder and board member of Tinnitus Quest.

They do not all study the same thing or advocate for the same treatment, and that is precisely what makes the gathering important. Tinnitus is too complicated to be understood through one theory, one device, or one discipline. For Dr. Keith Darrow, that conversation reflects a message he has spent years bringing to patients through what he describes as the Tinnitus Treatment Movement: tinnitus deserves to be investigated seriously, explained scientifically, and treated through an individualized clinical process rather than dismissed as something patients simply have to endure.

What This Article Covers

• Tinnitus Is More Than a Sound
• Dr. Stéphane Maison: What If the Audiogram Doesn’t Tell the Whole Story?
• Dr. Susan Shore: Understanding the Neural Circuits of Tinnitus
• Where Dr. Keith Darrow Fits Into This Scientific Conversation
• Seven Steps Instead of One Product
• Dr. Layne Garrett: Bringing Tinnitus Science Into the Clinic
• Hazel Goedhart and Tinnitus Quest: Patients Need a Seat at the Table
• From “Learn to Live With It” to “Let’s Understand It”

Tinnitus Is More Than a Sound

One of the most important changes in our understanding of tinnitus has been the recognition that it cannot be adequately explained by thinking about the ear alone. The sound may be perceived as ringing in the ears, but the perception ultimately involves neural activity. That distinction matters.

Dr. Darrow, a neuroscientist and clinical audiologist who trained at Harvard Medical School and MIT, has made this concept central to his patient education. His books on tinnitus — including Tinnitus Is Treatable, Silenced: The Medical Treatment of Tinnitus, and Quiet: Living With Less Tinnitus — translate complicated auditory neuroscience into language patients can understand.

One of his central messages is that patients should move beyond asking only, “How do I cover up the sound?” Instead, clinicians should investigate the auditory and neurological changes associated with a patient’s tinnitus, quantify its impact, determine appropriate treatment options, and then measure whether treatment is actually helping. That framework does not suggest every person with tinnitus needs the same intervention — quite the opposite. Modern tinnitus science increasingly shows why a one-size-fits-all approach is unlikely to address such a heterogeneous condition.

Dr. Stéphane Maison: What If the Audiogram Doesn’t Tell the Whole Story?

One of the most fascinating areas of modern hearing research involves something patients may never have heard about: cochlear synaptopathy, sometimes discussed in connection with “hidden hearing loss.”

Stéphane Maison, Ph.D., CCC-A, is an Associate Professor of Otolaryngology–Head and Neck Surgery at Harvard Medical School, clinical director of the Tinnitus Clinic at Massachusetts Eye and Ear, and a principal investigator in the Eaton-Peabody Laboratories. His research focuses on the peripheral auditory system, including whether auditory nerve damage can exist even when a conventional hearing test appears relatively normal.

Imagine being told, “Your hearing test looks normal,” yet you know something isn’t normal. Perhaps you struggle to understand conversation in restaurants. Perhaps sound feels different than it once did. Perhaps tinnitus appeared even though your standard audiogram does not show significant hearing loss.

Research from Maison and colleagues provides evidence that, in some people, a normal conventional audiogram may not capture all forms of auditory injury. This does not mean every person with tinnitus has hidden hearing loss. It does mean the scientific discussion has moved well beyond the simplistic idea that a normal audiogram necessarily means the entire auditory system is functioning normally. The absence of obvious hearing loss on a basic hearing test should not automatically end the investigation into a patient’s tinnitus.

Dr. Susan Shore: Understanding the Neural Circuits of Tinnitus

If Dr. Maison helps us look more closely at what may be happening between the cochlea and auditory nerve, Susan Shore, Ph.D., has spent decades investigating what happens farther along the pathway — in the brain.

Dr. Shore is Professor Emerita at the University of Michigan, where her research has focused on neural plasticity, multisensory integration, and tinnitus. Her work has been particularly important in understanding interactions between the auditory and somatosensory systems. This helps explain an experience familiar to some tinnitus patients: move your jaw, clench your teeth, turn your neck, or touch part of your face — and suddenly the tinnitus changes. Auditory processing does not exist in complete isolation from other sensory systems.

Dr. Shore’s research into auditory and somatosensory signals ultimately contributed to the development and clinical investigation of precisely timed auditory-somatosensory, or bisensory, stimulation. A randomized clinical study led by researchers at the University of Michigan reported encouraging findings from personalized bisensory stimulation in people with somatic tinnitus. The technology emerging from that research is being developed commercially through Auricle, a company Dr. Shore co-founded.

Her research reinforces a broader principle that is transforming tinnitus care: tinnitus involves neural circuitry capable of change, and understanding those circuits may eventually allow researchers to develop increasingly targeted interventions.

Where Dr. Keith Darrow Fits Into This Scientific Conversation

Dr. Darrow occupies a somewhat different place in the tinnitus ecosystem. Researchers such as Dr. Maison and Dr. Shore investigate specific biological mechanisms through laboratory and clinical research. Dr. Darrow’s work has focused heavily on translating auditory neuroscience into clinical education, patient communication, and structured tinnitus treatment processes.

Through his tinnitus books and educational programs, Darrow has argued for a change in the way tinnitus patients are treated: from dismissal to investigation; from coping alone to active clinical management; from one-size-fits-all recommendations to individualized treatment; from treating only the symptom to understanding the auditory and neurological system; and from “nothing can be done” to “let’s determine what can appropriately be done for you.”

This is the philosophy behind what Dr. Darrow describes as the Tinnitus Treatment Movement. It is not a single scientific hypothesis or a claim that one treatment is right for every patient. Rather, it encourages patients and professionals to recognize tinnitus as a legitimate clinical condition worthy of serious assessment and individualized care.

Seven Steps Instead of One Product

Perhaps the most important feature of Dr. Darrow’s tinnitus framework is that it is designed as a process, rather than a product.

1. Education: Patients first need an understandable explanation of tinnitus. Education does not eliminate tinnitus by itself, but understanding the condition can change how patients approach treatment.
2. Qualification: Not every case belongs exclusively in an audiology clinic. A responsible protocol begins by identifying relevant history, potential red flags, and patients who may require additional medical evaluation.
3. Quantification: Tinnitus can affect sleep, concentration, emotional wellbeing, social interaction, and quality of life differently from one patient to another. Validated questionnaires and structured assessments help document that burden.
4. Confirmation: Testing is useful only when findings are translated into something meaningful. Patients should understand what their evaluation found, what remains uncertain, and why a particular strategy is being considered.
5. Primary Treatment: The primary intervention should be selected according to the individual patient’s findings and needs — not simply according to whichever technology a clinic happens to sell.
6. Secondary Treatment: Some patients need additional support. Depending on the individual, management can combine hearing treatment, behavioral strategies, sound therapy, counseling, digital therapeutics, or emerging technologies such as bimodal stimulation.
7. Post-Treatment Tracking: Perhaps the most overlooked question is the simplest: is the patient actually getting better? Treatment should involve follow-up and measurement rather than ending when a device is delivered.

Dr. Layne Garrett: Bringing Tinnitus Science Into the Clinic

Research matters only if discoveries can eventually improve people’s lives. That makes experienced clinicians another essential part of the tinnitus conversation.

Layne Garrett, Au.D., is a board-certified audiologist and founder of Timpanogos Hearing & Tinnitus. His clinical work includes hearing technology, tinnitus management, behavioral approaches, and bimodal neuromodulation. Dr. Garrett also lives with tinnitus himself, giving him the perspectives of clinician, educator, and patient.

That perspective matters because laboratory science and everyday patient care operate on different timelines. Research asks, “What is biologically happening?” Clinical medicine must additionally ask, “What can we responsibly do for this patient today?” Good tinnitus care requires both.

Hazel Goedhart and Tinnitus Quest: Patients Need a Seat at the Table

There is another voice that belongs in this conversation: the patient’s.

Hazel Goedhart is a founder and board member of Tinnitus Quest, a patient-driven nonprofit created to accelerate tinnitus research and strengthen connections between researchers and the people living with the condition. Its leadership deliberately brings patients and scientists together, and its Scientific Advisory Board includes internationally recognized tinnitus researchers, including Susan Shore.

Scientists can measure neural firing. Audiologists can measure hearing. Researchers can study biomarkers. But patients can tell researchers whether tinnitus is destroying their sleep, whether they can concentrate at work, whether restaurants have become unbearable, whether treatment itself is burdensome, and whether their quality of life is actually improving. Those outcomes matter.

From “Learn to Live With It” to “Let’s Understand It”

These different perspectives represent pieces of a much larger puzzle. Dr. Maison investigates what damage may exist within the peripheral auditory system even when conventional testing does not reveal the whole story. Dr. Shore investigates how maladaptive neural activity and multisensory circuits contribute to tinnitus and whether those circuits can be targeted. Dr. Garrett asks how today’s available tools can be responsibly integrated into individualized care. Hazel Goedhart and Tinnitus Quest bring the priorities of patients into the research conversation. And Dr. Darrow asks how rapidly developing science can be translated into a structured clinical process that moves patients from confusion toward informed treatment.

For patients, perhaps the most important change is philosophical. For years, the endpoint of many tinnitus conversations was coping. Behavioral therapy, counseling, stress management, and sleep support can meaningfully improve quality of life and should remain part of appropriate care. But coping should not automatically mean ending the clinical investigation.

The Tinnitus Treatment Movement asks a broader question: what is contributing to this patient’s tinnitus, how is it affecting their life, what evidence-based options are appropriate, and how will we measure whether they are improving?

There is still much we don’t know. There is currently no universal cure that eliminates tinnitus for every person, and promising research does not guarantee that a particular therapy will work for a particular patient. Not every patient has cochlear synaptopathy. Not every patient has measurable hearing loss. Not every patient is a candidate for neuromodulation. That uncertainty isn’t evidence that tinnitus cannot be treated — it is evidence that tinnitus is complicated. And complicated medical problems require better science, not less science.

For the person lying awake tonight listening to ringing that nobody else can hear, that evolution matters. The conversation is no longer simply, “How do we help you tolerate tinnitus?” Researchers and clinicians are asking bigger questions: What changed within the auditory system? What changed within the brain? Can neural activity be changed? Which treatments work, and for whom? The science isn’t finished — but neither is the tinnitus patient’s story.

Patient information notice: This article is educational and is not a substitute for individualized medical advice, diagnosis, or treatment. New, sudden, pulsatile, one-sided, or otherwise concerning tinnitus should be evaluated by an appropriate healthcare professional.

Reviewed & edited by Keith N. Darrow, Ph.D., CCC-A, FAAA — July 29, 2026.